Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients.

Ming-Wei MaHong-Zhen LiXiao-Ying Li Ming-Zhu LiuHuan YinKai-Wei YangJia-Yan ChenXue-Ying RenDian Wang

Published in: Current oncology (Toronto, Ont.) (2022)

The early use of high-dose SABR to multi-lesions may improve survival. Partial-SABR for bulky lesions close to critical organs could be safely and effectively applied under certain circumstances.

Keyphrases

high dose
stem cell transplantation
low dose
early stage
single cell
cell therapy
radiation therapy
locally advanced
stem cells
type diabetes
squamous cell carcinoma
metabolic syndrome
adipose tissue
bone marrow
insulin resistance
skeletal muscle